Acute Hepatitis B in the Era of Immunisation: Pitfalls in the Identification of High Risk Patients

Overview

Journal Postgrad Med J

Publisher Oxford University Press

Specialty General Medicine

Date 2006 Mar 7

PMID 16517803

Authors

G Rosner

Y Lurie

L Blendis

Z Halpern

R Oren

Affiliations

Soon will be listed here.

Abstract

Background: Since the adoption of a universal hepatitis B immunisation strategy, the reported incidence of acute hepatitis B has declined dramatically worldwide including in Israel. However, new cases of acute hepatitis B still occur. The aim of this study was to describe the incidence of acute hepatitis B in a referral area, routes of transmission, and outcome.

Methods: The charts of all new hepatitis B patients, who visited the clinic in the years 2002 and 2003 (January 2002 to December 2003), were reviewed. The main criteria for a diagnosis of acute hepatitis B were transient increase of alanine transaminase activity, and hepatitis B surface antigen seroconversion.

Results: Twenty nine men and seven women were diagnosed with acute hepatitis B infection during the study period. Two patients were previously vaccinated with hepatitis B vaccine. One case of hepatitis D coinfection was reported. The incidence of acute hepatitis B in the referral area was estimated as 2.25 per 100,000 adult population. Mean age was 36 years (17-75). Twenty one patients (18 men and 3 women) acquired the virus through unprotected sexual contact, and seven patients through iatrogenic exposure. Thirty three patients underwent spontaneous seroconversion while three patients became chronic carriers.

Conclusions: Despite a universal immunisation policy, frequent cases of acute hepatitis B in Israel are still seen. High risk heterosexual activity and iatrogenic exposure seem to be the commonest routes of transmission. Further recommendations regarding vaccination policy are discussed.

References

Alter M . Epidemiology and prevention of hepatitis B. Semin Liver Dis. 2003; 23(1):39-46. DOI: 10.1055/s-2003-37583. View

Hagan H, Snyder N, Hough E, Yu T, McKeirnan S, Boase J . Case-reporting of acute hepatitis B and C among injection drug users. J Urban Health. 2002; 79(4):579-85. PMC: 3456717. DOI: 10.1093/jurban/79.4.579. View

Alter M, Hadler S, Margolis H, ALEXANDER W, Hu P, Judson F . The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA. 1990; 263(9):1218-22. View

Schwarcz S, Kellogg T, Kohn R, Katz M, Lemp G, Bolan G . Temporal trends in human immunodeficiency virus seroprevalence and sexual behavior at the San Francisco municipal sexually transmitted disease clinic, 1989-1992. Am J Epidemiol. 1995; 142(3):314-22. DOI: 10.1093/oxfordjournals.aje.a117637. View

Hagan H, Jarlais D, Friedman S, Purchase D, Alter M . Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health. 1995; 85(11):1531-7. PMC: 1615682. DOI: 10.2105/ajph.85.11.1531. View

Harpaz R, von Seidlein L, Averhoff F, Tormey M, Sinha S, Kotsopoulou K . Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med. 1996; 334(9):549-54. DOI: 10.1056/NEJM199602293340901. View

Gerberding J . The infected health care provider. N Engl J Med. 1996; 334(9):594-5. DOI: 10.1056/NEJM199602293340909. View

Schreiber G, Busch M, Kleinman S, Korelitz J . The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med. 1996; 334(26):1685-90. DOI: 10.1056/NEJM199606273342601. View

Hollinger F . Comprehensive control (or elimination) of hepatitis B virus transmission in the United States. Gut. 1996; 38 Suppl 2:S24-30. PMC: 1398039. DOI: 10.1136/gut.38.suppl_2.s24. View

10.

Williams A, Thomson R, Schreiber G, Watanabe K, Bethel J, Lo A . Estimates of infectious disease risk factors in US blood donors. Retrovirus Epidemiology Donor Study. JAMA. 1997; 277(12):967-72. View

11.

Mahoney F . Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev. 1999; 12(2):351-66. PMC: 88921. DOI: 10.1128/CMR.12.2.351. View

12.

Pebody R, Ruutu P, Nohynek H, Leinikki P . Changing epidemiology of hepatitis B infection in Finland. Scand J Infect Dis. 1999; 31(3):251-4. DOI: 10.1080/00365549950163527. View

13.

HELCL J, castkova J, Benes C, Novotna L, Sepkowitz K, DeHovitz J . Control of occupational hepatitis B among healthcare workers in the Czech Republic, 1982 to 1995. Infect Control Hosp Epidemiol. 2000; 21(5):343-6. PMC: 2925678. DOI: 10.1086/501771. View

14.

Mansson A, Moestrup T, Nordenfelt E, Widell A . Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program. Scand J Infect Dis. 2000; 32(3):253-8. DOI: 10.1080/00365540050165875. View

15.

Lindh M, Horal P, Norkrans G . Acute hepatitis B in Western Sweden--genotypes and transmission routes. Infection. 2000; 28(3):161-3. DOI: 10.1007/s150100050071. View

16.

Hagan H, Thiede H . Changes in injection risk behavior associated with participation in the Seattle needle-exchange program. J Urban Health. 2000; 77(3):369-82. PMC: 3456035. DOI: 10.1007/BF02386747. View

17.

Remis R, Dufour A, Alary M, Vincelette J, Otis J, Masse B . Association of hepatitis B virus infection with other sexually transmitted infections in homosexual men. Omega Study Group. Am J Public Health. 2000; 90(10):1570-4. PMC: 1446361. DOI: 10.2105/ajph.90.10.1570. View

18.

. Hepatitis B vaccination in countries with low endemicity. Prescrire Int. 2001; 9(45):213-9. View

19.

Stroffolini T, Mele A, Tosti M, Gallo G, Balocchini E, Ragni P . The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy. J Hepatol. 2000; 33(6):980-5. DOI: 10.1016/s0168-8278(00)80132-4. View

20.

Slusarczyk J . Vaccination against hepatitis viruses in Poland. Vaccine. 2001; 19(17-19):2384-8. DOI: 10.1016/s0264-410x(00)00459-x. View